The nation of Zimbabwe has turned down a substantial US health deal worth $367m (272 million pounds) spanning five years due to the United States' request for confidential data.
This move came to light following a government memo from December was leaked, which showed Head of State Emmerson Mnangagwa felt the arrangement was "skewed".
An official representative has since explained that the US was seeking biological samples for scientific study and profit but refused to guarantee the benefits from future vaccines.
"We must now begin the challenging and unfortunate process of scaling back our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for further negotiations to reach a agreement acceptable to all parties so the nation's vital HIV programme can continue.
Broader Implications
This rejection comes after a comparable case in Kenya, where a high court halted a related deal with the US following legal challenges were filed about the security of Kenyans' health data.
After returning to office last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had managed aid for the US government, but Trump stated its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to boost openness and accountability.
As per statements, 16 African countries have to date signed similar agreements, representing over $18.3bn in new funding.
Details of the Rejected Deal
This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration could have provided extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million currently on HIV treatment through American-funded programmes," Tremont commented.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"Our nation was requested to surrender its biological resources and data over an extended period, without any corresponding promise of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," Mangwana explained.
"In essence, our country would provide the basic resources for medical research without any assurance that the resulting innovations would be available to our citizens should a future disease outbreak arise."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending frameworks already established via the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to manage future pandemics.
"This system is designed to ensure that when a country contributes its data, the benefits – including vaccines and treatments – are shared equitably, not commercialised solely by those with the capability to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We are open to ongoing discussions with our American counterparts on how future co-operation might be designed in a manner that respects the independence and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but recommended that negotiations need to persist given that much of the country's HIV programmes were funded by external financing.
"Where technical issues exist, such as those relating to data governance or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," the group added.
The situation highlights the ongoing tensions between receiving crucial international aid and safeguarding local interests in an increasingly data-driven world.